-
‘Naively Ambitious’: How COVAX Failed on its Promise to Vaccinate the World Opens in a new window)
Conceived at the start of the pandemic, COVAX had lofty goals, promising fair and equitable access to Covid-19 vaccines for every country worldwide, and giving them for free to the poorest. -
Africans Welcome New Malaria Vaccine. But Is It a ‘Game Changer'? Opens in a new window)
When babies are born in western Kenya, where malaria is rife, many mothers are sent home from the hospital with one all-important baby gift: a bed net treated with insecticide.Comments
-
Buyers Clamor for Merck's COVID-19 Antiviral Molnupiravir, but Pricing is Already Controversial Opens in a new window)
Less than a week after Merck and Ridgeback released extraordinary data on the effectiveness of experimental COVID-19 drug molnupiravir, the rush is on to lock up supplies.Comments
-
Venezuelans Rely on the Kindness of Strangers to Pay for COVID-19 Treatment Opens in a new window)
The state of Venezuela's already overloaded and crumbling public health system, in which hospitals often lack access to even water, has pushed many to use costly private centers.Comments
-
WHO Prioritizes Access to Diabetes and Cancer Treatments in New Essential Medicines Lists Opens in a new window)
High prices and low availability still a major barrier for patients’ access to new and old medicines.Comments
-
For the First Time, WHO Committee Recommends Action on High-Priced Essential Medicines Opens in a new window)
The suggestion was made in the latest report about treatments to be added to the WHO list of essential medicines.Comments
-
What's Fueling the World's Covid-19 Vaccination Disparity?
Amnesty international has warned covid-19 developers not to put profits before lives.Comments
-
WHO Adds Regeneron Drug to Recommended Covid-19 Treatments, but Criticizes its Pricing Opens in a new window)
As part of their message, the agencies also urged Regeneron to transfer technology used to make its monoclonal antibody to other manufacturers so that lower-cost biosimilar versions could be made more quickly for low and middle-income nations.Comments
-
A W.H.O. Panel Recommends Treating High-Risk Covid Patients with Monoclonal Antibodies. Opens in a new window)
In the United States, some health experts have worried that promoting the therapy, which the government covers at a cost of $2,100 per dose, was taking away time and money from the effort to get more Americans vaccinated against Covid.Comments
-
WHO Backs Regeneron Drug for COVID-19, Urges Action on Price Opens in a new window)
The health agency urged Regeneron, which holds the patent, to lower the drug’s price and work on equitable distribution worldwide.Comments
-
A Double Dose of Inequality: Pharma Companies and the Covid-19 Vaccines Crisis
New report shows leading Covid-19 vaccine pharma companies fuelling unprecedented human rights crisis.Comments
-
WHO Backs Regeneron COVID-19 Drug Cocktail as UN Body Calls for Equal Access Opens in a new window)
The treatment has been granted U.S. emergency use authorisation, having gained attention when used to treat former President Donald Trump's COVID-19 illness last year.Comments
-
Access to Cancer Medicines Deemed Essential by Oncologists in 82 Countries: An International, Cross-Sectional Survey Opens in a new window)
This international, cross-sectional survey was developed by investigators from a range of clinical practice settings across low-income to high-income countries, including members of the WHO Essential Medicines Cancer Working Group.Comments
-
Biden to Push Global Plan to Battle Covid as National Gaps Widen Opens in a new window)
The U.N.-backed vaccine program is so far behind schedule that not even 10 percent of the population in poor countries is fully vaccinated, experts say.Comments
-
U.S. to Buy Millions of Pfizer Vaccine Doses to Donate to World Opens in a new window)
The purchase was to be announced early next week to coincide with the United Nations General Assembly meeting in New York.Comments
Comments